A number of other equity analysts have also published reports on ATGE. BMO Capital Markets cut its price target on Adtalem Global Education from $37.00 to $32.00 in a Thursday, February 10 report. Zacks Investment Research downgraded Adtalem Global Education from a “hold” rating to a “strong sell” rating and set a target price of $20.00 for the company. in a research report on Tuesday, February 15. One analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned the company a buy rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $34.00.
ATGE shares opened at $30.24 on Thursday. Adtalem Global Education has a 12 month minimum of $19.14 and a 12 month maximum of $41.34. The company has a market capitalization of $1.51 billion, a price-earnings ratio of -201.60, a growth price-earnings ratio of 0.67 and a beta of 1.12. The company has a 50-day simple moving average of $25.94 and a 200-day simple moving average of $30.73. The company has a debt ratio of 1.24, a current ratio of 1.23 and a quick ratio of 1.23.
Adtalem Global Education (NYSE: ATGE – Get a rating) last released its quarterly earnings data on Tuesday, February 8. The company reported earnings per share (EPS) of $0.75 for the quarter, missing analyst consensus estimates of $0.96 per ($0.21). Adtalem Global Education recorded a positive return on equity of 10.93% and a negative net margin of 0.51%. The company posted revenue of $371.20 million in the quarter, versus a consensus estimate of $419.27 million. During the same period last year, the company earned earnings per share of $0.77. The company’s quarterly revenue increased by 58.4% compared to the same quarter last year. On average, equity analysts expect Adtalem Global Education to post 3 EPS for the current financial year.
Separately, director Kenneth J. Phelan acquired 4,087 shares of the company in a transaction dated Thursday, February 10. The stock was purchased at an average price of $24.47 per share, for a total transaction of $100,008.89. The purchase was disclosed in a filing with the SEC, accessible via this hyperlink. Additionally, director Sharon O’keefe acquired 1,250 shares of the company in a transaction dated Wednesday, February 23. The shares were purchased at an average price of $20.63 per share, with a total value of $25,787.50. Disclosure of this purchase can be found here. Insiders have acquired 50,357 shares of the company worth $1,189,521 in the past 90 days. 2.75% of the shares are currently held by insiders.
Major investors have recently changed their positions in the company. Marshall Wace North America LP acquired a new position in shares of Adtalem Global Education in the first quarter worth $56,000. Morgan Stanley increased its position in Adtalem Global Education by 66.6% during the second quarter. Morgan Stanley now owns 79,200 shares of the company worth $2,821,000 after buying 31,647 more shares in the last quarter. Pacer Advisors Inc. increased its position in Adtalem Global Education by 1,717.3% during the third quarter. Pacer Advisors Inc. now owns 96,133 shares of the company worth $3,635,000 after purchasing an additional 90,843 shares in the last quarter. The Oregon Public Employees Retirement Fund increased its holdings in Adtalem Global Education by 16.6% during the third quarter. The Oregon Public Employees Retirement Fund now owns 19,926 shares of the company valued at $753,000 after acquiring 2,844 additional shares during the period. Finally, SummerHaven Investment Management LLC purchased a new stake in Adtalem Global Education during the third quarter, valued at approximately $882,000. 98.28% of the shares are currently held by institutional investors.
Adtalem Global Education Company Profile (Get a rating)
Adtalem Global Education Inc provides workforce solutions worldwide. It operates through two segments, Medical and Healthcare; and Financial Services. The Medical and Healthcare segment offers degree and non-degree programs in the medical and healthcare post-secondary education sector. This segment operates Chamberlain University, American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Adtalem Global Education right now?
Before you consider Adtalem Global Education, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes hold…and Adtalem Global Education was not on the list.
Although Adtalem Global Education currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here